This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

When asked about the company's growth prospects, Sherif said Medidata touches almost 50% of all new clinical trials, but currently only has 3% to 4% penetration in the space. That leaves a long road for adoption, he continued.

Cramer said sometimes you don't get a chance to buy low and sell high with high-flying stocks. Sometimes you have to hold your nose and buy high so you can sell even higher.

Know Your IPO

In his "Know Your IPO" segment, Cramer went to the movies with the upcoming IPO of AMC Entertainment, which will be coming public next week under the all-too-obvious ticker, AMC.

Cramer said that AMC Entertainment should not be confused with AMC Networks (AMCX) -- this one is the second-largest movie theater chain in the U.S. with 343 locations totaling 4,950 screens. The company plans to offer 18.4 million shares between $18 and $20, giving it a market cap around $1.8 billion.

Cramer said AMC is absolutely worth owning, even up to $23 a share in the aftermarket, because the company is taking control of its own destiny and proving the naysayers wrong time and time again.

How can movie theaters compete with the ultimate convenience of Netflix (NFLX)? Innovation. Cramer said. AMC has 34% market share in our nation's top five markets and has the highest margins thanks to higher-than-average ticket prices and concessions.

But AMC is not sitting still -- the company is building larger screens to directly take on IMAX (IMAX) and is adding reclining seats and dining options, including seat-side service at some of its locations. This is turning the movies into a must-see destination, said Cramer, and something moviegoers are loving.

AMC also plans of sporting a dividend around 4.2%, which is something shareholders will love, said Cramer.

Lightning Round

In the Lightning Round, Cramer was bullish on Discover Financial Services (DFS), Zoetis (ZTS), Baxter International (BAX), Nokia (NOK), Alcatel Lucent (ALU) and SandRidge Energy (SD).

Cramer was bearish on Pfizer (PFE) and VeriFone (PAY).

Executive Decision: Doug Tough

For his second "Executive Decision" segment, Cramer spoke with Doug Tough, chairman and CEO of International Flavors & Fragrances (IFF - Get Report), a stock that's up 41% since Cramer last checked in 16 months ago, but also one that's five points off its highs.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
IFF $117.50 0.77%
MDSO $56.28 1.30%
AAPL $123.98 -1.40%
FB $77.81 0.32%
GOOG $523.88 -1.30%

Markets

DOW 17,791.10 -137.10 -0.76%
S&P 500 2,076.84 -12.62 -0.60%
NASDAQ 4,908.6610 -30.6660 -0.62%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs